Defining and Characterizing the Progression of Type 2 Diabetes

被引：275
作者：
Fonseca, Vivian A. [1 ]
机构：
[1] Tulane Univ, Med Ctr, New Orleans, LA 70118 USA
来源：
DIABETES CARE | 2009年 / 32卷
关键词：
BETA-CELL FUNCTION; BLOOD-GLUCOSE CONTROL; INSULIN-RESISTANCE; TOLERANCE; DISEASE; COMPLICATIONS; THERAPY; FAILURE; INTOLERANCE; PREDICTORS;
D O I：
10.2337/dc09-S301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S151 / S156
页数：6
相关论文
共 37 条
[11]   Mode of onset of type 2 diabetes from normal or impaired glucose tolerance [J].
Ferrannini, E ;
Nannipieri, M ;
Williams, K ;
Gonzales, C ;
Haffner, SM ;
Stern, MP .
DIABETES, 2004, 53 (01) :160-165
[12]   The natural course of β-cell function in nondiabetic and diabetic individuals -: The insulin resistance atherosclerosis study [J].
Festa, A ;
Williams, K ;
D'Agostino, R ;
Wagenknecht, LE ;
Haffner, SM .
DIABETES, 2006, 55 (04) :1114-1120
[13]   SIZE OF PANCREAS IN DIABETES-MELLITUS - A STUDY BASED ON ULTRASOUND [J].
FONSECA, V ;
BERGER, LA ;
BECKETT, AG ;
DANDONA, P .
BRITISH MEDICAL JOURNAL, 1985, 291 (6504) :1240-1241
[14]   β-cell genes and diabetes -: Molecular and clinical characterization of mutations in transcription factors [J].
Frayling, TM ;
Evans, JC ;
Bulman, MP ;
Pearson, E ;
Allen, L ;
Owen, K ;
Bingham, C ;
Hannemann, M ;
Shepherd, M ;
Ellard, S ;
Hattersley, AT .
DIABETES, 2001, 50 :S94-S100
[15]   Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention) [J].
Gerstein, Hertzei C. .
AMERICAN HEART JOURNAL, 2008, 155 (01) :26-32
[16]   Pancreatic volume in type 1 and type 2 diabetes mellitus [J].
Goda, K ;
Sasaki, E ;
Nagata, K ;
Fukai, M ;
Ohsawa, N ;
Hahafusa, T .
ACTA DIABETOLOGICA, 2001, 38 (03) :145-149
[17]   Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes [J].
Hull, RL ;
Westermark, GT ;
Westermark, P ;
Kahn, SE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :3629-3643
[18]   Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes [J].
Kahn, SE ;
Andrikopoulos, S ;
Verchere, CB .
DIABETES, 1999, 48 (02) :241-253
[19]   Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy [J].
Kahn, Steven E. ;
Haffner, Steven M. ;
Heise, Mark A. ;
Herman, William H. ;
Holman, Rury R. ;
Jones, Nigel P. ;
Kravitz, Barbara G. ;
Lachin, John M. ;
O'Neill, M. Colleen ;
Zinman, Bernard ;
Viberti, Giancarlo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2427-2443
[20]   Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism [J].
Kumar, Anjali F. ;
Gruessner, Rainer W. G. ;
Seaquist, Elizabeth R. .
DIABETES CARE, 2008, 31 (08) :1639-1643
1234